WallStSmart
MDWD

Mediwound Ltd

NASDAQ: MDWD · HEALTHCARE · BIOTECHNOLOGY

$16.25
-1.87% today

Updated 2026-04-29

Market cap
$208.85M
P/E ratio
P/S ratio
12.31x
EPS (TTM)
$-2.10
Dividend yield
52W range
$15 – $23
Volume
0.1M

Mediwound Ltd (MDWD) Earnings

Quarterly earnings history, analyst estimates, and stock price reaction.

EPS beat streak
4 of 8
Last 8 quarters
Avg EPS surprise
+19.7%
Last 4 quarters
Revenue YoY growth
-68.0%
Most recent quarter
EPS YoY growth
-55.6%
Most recent quarter

Earnings surprise history (last 12 quarters)

Beat estimate Missed estimate

Quarterly EPS and revenue trend

Quarterly revenue EPS (diluted)

How the stock reacts to earnings

Avg 1-day reaction
-4.1%
Last 2 reports
Positive reaction rate
0%
0 of 2 quarters
Largest single-day move
-4.5%
2025-11-20
Report dateEPS actualSurpriseClose beforeClose after1-day reaction
2026-03-12$-0.56+34.0%$17.22$16.58-3.7%
2025-11-20$-0.24+70.5%$17.86$17.06-4.5%

Quarterly earnings history

Fiscal quarter endingEPS estimateEPS actualSurpriseRevenueYoY revenue
2025-12-31$-0.85$-0.56+34.0%$1.87M-68.0%
2025-09-30$-0.81$-0.24+70.5%$5.43M+24.7%
2025-06-30$-0.57$-1.23-115.1%$5.71M+12.7%
2025-03-31$-0.66$-0.07+89.4%$3.96M-20.3%
2024-12-31$-0.61$-0.36+40.7%$5.84M+9.4%
2024-09-30$-0.44$-0.98-122.7%$4.36M-8.8%
2024-06-30$-0.42$-0.68-61.9%$5.06M+6.1%
2024-03-31$-0.41$-1.05-156.1%$4.96M+30.7%
2023-12-31$-0.23$-0.19+17.4%$5.34M
2023-09-30$-0.44$-0.24+45.5%$4.78M
2023-06-30$-0.40$0.10+125.0%$4.77M
2023-03-31$-0.30$-0.44-46.7%$3.80M
2022-12-31$-0.59$-1.18-100.0%

Frequently asked questions

Has Mediwound Ltd beaten earnings estimates?
Mediwound Ltd has beaten Wall Street EPS estimates in 4 of its last 8 quarterly reports, with an average EPS surprise of +19.7% over the last 4 quarters.
How does MDWD stock react to earnings?
MDWD stock has moved an average of -4.1% in the trading day following earnings over its last 2 reports, with positive reactions in 0% of those quarters.
What is Mediwound Ltd's revenue growth rate?
Mediwound Ltd reported year-over-year revenue growth of -68.0% in its most recent quarter, with EPS growing -55.6% year-over-year.